KCT0003876招募中未知
A 12 week, multi center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of GF2 on atopic dermatitis in children
Samyang0 个研究点目标入组 70 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 1(Year) 至 11(Year)（—）
- 性别
- All
入选标准
- •1)subject who signs Informed Consent Form with a legal representative who signs the informed consent form before participating in the study
- •2)subject aged between 1 years and 11 years with atopic dermatitis
- •3)subject with intermittent or continuous atopic dermatits symptom over 6 months
- •4)subject with SCORing of Atopic Dermatitis index between 25 and 50 (moderate)
排除标准
- •1)subject with other systemic illnesses or dermatits history except Atopic Dermatitis
- •2)subject administrating immunosuppressant,antobiotics,corticosteroid, antihistaminic within 4 weeks
- •3)subject who has taken medicines,chinese medicine, health functional foods within 4 weeks for improvement of atopic dermatiti
- •4) subject who has treatened phototherapy
研究者
相似试验
招募中
不适用
A 12 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of SKBE on atopic dermatitis in childreKCT0003259ifetree Biotech80
已完成
不适用
A 12 week, phase II trial to evaluate the efficacy and safety of WIN-34B in patients with Osteoarthritis of the kneeDiseases of the musculo-skeletal system and connective tissueKCT0000732Hamsoa Pharmaceutical150
招募中
不适用
A 12 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of NIHHS-19-01 on improving liver functioDiseases of the digestive systemKCT0004797Chosun University90
招募中
不适用
A 12 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of SCE on atopic dermatitis in childreKCT0002233ovarex80
尚未招募
不适用
A 12 week, multi-center, double-blind, randomized, placebo-controlled clinical trial for the evaluation of the efficacy and safety of opuntia ficus-indica extract on improving liver funtion.KCT0000867Elcomscience80